Centene: Big Comeback Story
Centene Corporation reported a strong Q1 earnings beat, driven by higher revenue and improved cost efficiency, signaling a significant turnaround after a tough year for health insurers. Revenue reached $49.94 billion, surpassing expectations, while improved margins contributed to a substantial EPS beat. The company raised its full-year 2026 guidance, forecasting at least $3.40 in adjusted EPS. This performance supports renewed investor confidence and a potential re-rating of the stock.
- ▪Centene's Q1 revenue was $49.94 billion, $2.4 billion above consensus and up 7.1% year-over-year.
- ▪The health benefits ratio improved to 87.3%, reflecting better cost discipline.
- ▪SG&A expenses declined, contributing to a $1.24 adjusted EPS beat versus analyst expectations.
- ▪Centene raised its 2026 guidance, projecting at least $3.40 in adjusted EPS, a 63.4% increase from the prior year.
- ▪The stock's performance reflects a broader recovery in the health insurance sector after a challenging period.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895307-centene-big-comeback-story"},"author":{"@type":"Person","name":"Quad 7 Capital","url":"https://seekingalpha.com/author/quad-7-capital"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.